-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

631. Myeloproliferative Syndromes and Chronic Myeloid Leukemia: Basic and Translational: Poster III

Symposia: Myeloproliferative Syndromes and Chronic Myeloid Leukemia: Basic and Translational Program: Oral and Poster Abstracts
Type: Poster
Monday, December 12, 2022: 6:00 PM-8:00 PM
Hall D (Ernest N. Morial Convention Center)

Garima Pandey*, Nathan Horvat*, Narmin E. Amin*, Guolin Zhang*, Lucia Mazzacurati*, Afua A. Akuffo*, Christelle Colin-Leitzinger*, Eric B. Haura*, Pearlie K. Epling-Burnette* and Gary W. Reuther, PhD

Moffitt Cancer Center, Tampa, FL

Frederike Kramer, PhD1, Anna E Marneth, PhD1, Olga Pozdnyakova, MD, PhD2*, Jessica Hem1*, Malvina Papanastasiou, PhD3*, Andrew Reiter3*, Steven A Carr, PhD4* and Ann Mullally, MD1,5,6

1Division of Hematology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA
2Department of Pathology, Brigham and Women's Hospital, Boston, MA
3Broad Institute of MIT and Harvard, Cambridge, MA
4Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA
5Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
6Broad Institute, Cambridge, MA

Gu Wenjing, MD1*, Jingyuan Tong1*, Rongfeng Fu, MD2*, Lihong Shi1* and Lei Zhang, MD3*

1State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
2CAMS Key Laboratory of Gene Therapy for Blood Diseases, Tianjin Key Laboratory of Gene Therapy for Blood Diseases, Tianjin, China
3State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences, Tianjin, China

Marc Usart1*, Cédric B. Stoll2*, Riikka Karjalainen2*, Hui Hao-Shen2* and Radek C. Skoda2

1Department of Biomedicine, Experimental Hematology, University Hospital Basel and University of Basel, Basel, Basel-Stadt, Switzerland
2Department of Biomedicine, Experimental Hematology, University Hospital Basel and University of Basel, Basel, Switzerland

Meenu Kesarwani1*, Mohammad Azhar, PhD2*, Zachary Kincaid, BS3* and Mohammad Azam, PhD4

1Cincinnati Childrens Hospital Medical Center, Mason, OH
2Cincinnati Children's Hospital Medical Center, Cincinnati, OH
3Cincinnati Childrens Hospital Medical Center, Cincinnati, OH
4CBDI, Cincinnati Children's Hospital, Cincinnati, OH

Rebecca Austin1,2,3*, Madeline Kowalski, MS3,4,5*, Xiaoli Wang, PhD6*, Bettina Nadorp, PhD7,8,9*, Audrey Lasry, PhD1,2*, Zhengxi Sun, M.Phil1,2*, Julia Rojo-Tomillo1,2*, Andrew Davis, MS6*, Dimitrios Papaioannou, MD1,2*, Rahul Satija, PhD4,5,10*, Ioannis Aifantis, PhD1,2* and Ronald Hoffman, MD6

1Department of Pathology, NYU Grossman School of Medicine, New York, NY
2Laura and Isaac Perlmutter Cancer Center, NYU Grossman School of Medicine, New York, NY
3Equal contribution, #
4Institute for Systemics Genetics, NYU Grossman School of Medicine, New York, NY
5New York Genome Center, New York, NY
6Division of Hematology/Medical Oncology, Tisch Cancer Institute, Ichan School of Medicine at Mount Sinai, New York, NY
7Applied Bioinformatics Laboratories, NYU Grossman School of Medicine, New York, NY
8Department of Pathology, New York University School of Medicine, New York, NY
9Laura and Isaac Perlmutter Cancer Center, New York University School of Medicine, New York, NY
10Center for Genomics and Systems Biology, New York University, New York

Niccolò Bartalucci, PhD, BSc1*, Laura Calabresi, PhD1*, Manjola Balliu, PhD1*, Danilo Tarantino, PhD1*, Simone Romagnoli, PhD1*, Alessio Enderti1*, Francesca Arciprete2*, Maria Zingariello, PhD2*, Christian A Di Buduo, PhD3*, Alessandra Balduini4*, Anna Rita Migliaccio, PhD5, Paola Guglielmelli, MD, PhD6 and Alessandro M Vannucchi, MD1

1CRIMM, Center Research and Innovation of Myeloproliferative Neoplasms, University of Florence, AOU Careggi, Florence, Italy
2Unit of Microscopic and Ultrastructural Anatomy, Dept of Medicine, University Campus Bio-Medico Roma, Rome, Italy
3Department of Molecular Medicine, University of Pavia, Pavia, Italy
4University of Pavia, Pavia, Italy
5Medicine and Surgery, University Campus Bio-Medico, Rome, Italy
6CRIMM, Center of Research and Innovation of Myeloproliferative Neoplasms, University of Florence, AOU Careggi, Florence, Italy

Ho-Jae Han, PhD1*, Hyeok-Jae Jang1*, Youngseok Yoo2*, Taehyung Simon Kim2*, Jong-Won Kim, MD, PhD3* and Dennis Dong Hwan Kim, MD, PhD4

1Samsung Medical Center, Department of Health Sciences and Technology, Samsung Advanced Institute for Health Sciences and Technology, Sungkyunkwan University, Seoul, Korea, Republic of (South)
2Princess Margaret Cancer Centre, Toronto, ON, Canada
3Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, KOR
4Department of Medical Oncology & Hematology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON, Canada

Guadalupe Rojas Sanchez, Ph D1*, Orlando Esparza, MD2, Brandon McMahon, MD3, Giovanny Hernandez, BS4*, Dennis Le, BS1*, Travis Nemkov, PhD5*, Angelo D'Alessandro, PhD6, Andrew Thorburn, Ph D7*, José A. López, MD8 and Pavel Davizon-Castillo, MD1*

1University of Colorado - Pediatric Hematology/Oncology/BMT, Aurora, CO
2Department of Pediatrics Hematology/Oncology and Bone Marrow Transplantation, University of Colorado Anschutz Medical Campus, Denver, CO
3Division of Hematology, University of Colorado Anschutz Medical Campus, Aurora, CO
4Department of Pediatrics Hematology/Oncology and Bone Marrow Transplantation, University of Colorado Anschutz Medical Campus, Aurora, CO
5University of Colorado Anschutz Medical Campus, University, Aurora, CO
6Department of Biochemistry and Molecular Genetics, University of Colorado School of Medicine, Aurora, CO
7University of Colorado Anschutz Medical Center, Department of Pharmacology, Aurora, CO
8Bloodworks Northwest Research Institute, Seattle, WA

John Mascarenhas, MD1, Aaron T. Gerds, MD, MS2, Jean-Jacques Kiladjian, MD3, Konstanze Döhner, MD4, Sarah Buckley, MD5*, Jennifer A. Smith, PhD5*, Adam R Craig, MD, PhD5, Simran Bedi Singh6*, Srdan Verstovsek, MD, PhD7 and Claire N. Harrison, DM8

1Department of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY
2Department of Hematology and Medical Oncology,, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH
3Hopital Saint-Louis, Paris, France
4Ulm University Hospital, Ulm, Germany
5CTI BioPharma, Seattle, WA
6CTI Biopharma, Seattle, WA
7Leukemia Department, The University of Texas MD Anderson Cancer Center, Houston, TX
8Guy's and St Thomas' NHS Foundation Trust, London, ENG, United Kingdom

Raveen Stephen Stallon Illangeswaran, MSc1*, Bharathi M Rajamani, M.Phil1*, Esther Sathya Bama Benjamin, M.Tech1*, Saswati Das, Msc1*, Daniel Zechariah Paul Jebanesan, M.Tech1*, Vikram Mathews, MD, DM1, Shaji Ramachandran Velayudhan, PhD1,2* and Poonkuzhali Balasubramanian, MSc, PhD1

1Department of Haematology, Christian Medical College, Vellore, India
2Centre for Stem Cell Research, Christian Medical College, Vellore, India

C. Matthias Wilk, MD1*, Brooks Scull, MS2*, Ryan Fleischmann, MS2*, Tsz-Kwong Man, PhD3*, Kenneth L. McClain, MD, PhD4, Miriam Merad, MD, PhD5*, Florent Ginhoux, PhD6* and Carl E. Allen, MD, PhD7

1Precision Immunology Institute and Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY
2Texas Children's Cancer Center, Texas Children's Hospital, Houston, TX
3Texas Children's Cancer and Hematology Centers, Baylor College of Medicine, Houston, TX
4Texas Childrens Cancer and Hematology Centers, Houston, TX
5Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY
6Singapore Immunology Network ( SIgN), Agency for Science, Technology and Research ( A *STAR), Singapore, Singapore
7Division of Pediatric Hematology and Oncology, Baylor College of Medicine, Houston, TX

Ernesto J Cuenca1,2*, Pedro J Guijarro-Carrillo, BSc3*, María J López-Poveda, MD4*, Paula Durán-Espin, BSc3*, Eva Soler, MD3*, María Luz Morales3*, Maria Luisa Lozano, MD, PhD1,3*, Alberto Alvarez-Larran, MD, PhD5*, Nuria Garcia-Barbera, BSc3*, Rocio Gonzalez-Conejero, PhD3*, Constantino Martínez, PhD3*, Raul Teruel Montoya, PhD1,3* and Francisca Ferrer Marin, MD, PhD1,3,6

1CIBERER U-765, Murcia, Spain
2Centro Regional De HemodonacióN, Murcia, Spain
3Servicio de Hematología y Oncología Médica. H.U. Morales Meseguer. Centro Regional de Hemodonación. Universidad de Murcia. IMIB-Arrixaca, Murcia, Spain
4Servicio de Anatomía Patológica. H.U. Morales Meseguer, Murcia, Spain
5Hematology Department, Hospital Clínic, Barcelona, Spain
6UCAM, Murcia, Spain

Lara Tavernari1*, Sebastiano Rontauroli1*, Monica Maccaferri2*, Barbara Mora3*, Elia Venturelli1*, Elisa Bianchi1*, Sandra Parenti1*, Elena Genovese1*, Paola Guglielmelli, MD, PhD4, Chiara Carretta1*, Margherita Mirabile1*, Stefano Sartini1*, Corrado Colasante5*, Leonardo Potenza5*, Francesco Passamonti, MD3*, Enrico Tagliafico5,6*, Mario Luppi5*, Alessandro M. Vannucchi4 and Rossella Manfredini1*

1Centre for Regenerative Medicine "S. Ferrari", University of Modena and Reggio Emilia, Modena, Italy
2Department of Laboratory Medicine and Pathology, Diagnostic Hematology and Clinical Genomics, AUSL/AOU Policlinico, Modena, Italy
3Division of Hematology, Ospedale ASST Sette Laghi, University of Insubria, Varese, Italy
4Department of Experimental and Clinical Medicine, and Center Research and Innovation of Myeloproliferative Neoplasms (CRIMM), University of Florence, Careggi University Hospital, Florence, Italy
5Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, AOU Policlinico, Modena, Italy
6Center for Genome Research, University of Modena and Reggio Emilia, Modena, Italy

Yenny Moreno Vanegas, MD, BSc1, Ahmad Nanaa, MD2,3, Aref Al-Kali, MD4, Rong He, MD5, Hassan B. Alkhateeb, MD4*, Mrinal M. M. Patnaik, MD4, Naseema Gangat, MBBS4, Mithun V. Shah, MD, PhD4, Mark R. Litzow, MD4, Ayalew Tefferi, MD4 and Talha Badar, MD6

1Division of Hematology/Oncology and Blood and Marrow Transplanation and Cellular Therapy, Mayo Clinic, Jacksonville, FL
2Division of Hematology, John H. Stroger, Jr. Hospital of Cook County, Chicago, IL
3Mayo Clinic/Rochester/Hematology, Mayo Clinic, ROCHESTER
4Division of Hematology, Mayo Clinic, Rochester, MN
5Division of Hematopathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
6Division of Hematology and Oncology, Mayo Clinic Florida, Jacksonville, FL

Vibe Skov, PhD1*, Mads Thomassen, PhD2*, Lasse Kjær, PhD1*, Morten Kranker Larsen, MSc1*, Christina Ellervik, PhD3,4,5,6*, Trine Alma Knudsen1*, Torben A. Kruse2* and Hans Carl Hasselbalch, MD1

1Department of Hematology, Zealand University Hospital, Roskilde, Denmark
2Department of Clinical Genetics, Odense University Hospital, Odense, Denmark
3Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
4Department of Production, Research, and Innovation, Region Zealand, Sorø, MA, Denmark
5Department of Laboratory Medicine, Boston Children's Hospital, Boston, MA
6Department of Pathology, Harvard Medical School, Boston, MA

Ariel Monet Leyte-Vidal, B.S.1* and Neil P. Shah, MD, PhD2

1University of Miami, Miami, FL
2Department of Medicine/Hematology-Oncology, UCSF School of Medicine, San Francisco, CA

*signifies non-member of ASH